Medical Condition News

RSS

Startup receives federal grant for developing technology to detect and treat stress, anxiety

A high-tech startup that uses game-based interventions to help users identify stress- and anxiety-related events in real time and receive a personalized intervention has been awarded a federal grant to partially develop its technology through research at Purdue University's College of Engineering.

28 Oct 2022

CHG may be the most effective irrigation solution for use during surgical treatment of bone tumors

The widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, suggests an experimental study in The Journal of Bone & Joint Surgery.

28 Oct 2022

UK Markey Cancer Center earns the rigorous NAPRC accreditation

The University of Kentucky Markey Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer.

28 Oct 2022

Cleveland Clinic awarded $12 million NIH grant to define how cytokines regulate inflammation

Cleveland Clinic's Lerner Research Institute was awarded a five-year $12 million grant by the National Cancer Institute, part of the National Institutes of Health, to define how cytokines - proteins produced during immune response - regulate inflammation and interact with cells and molecules surrounding tumors.

28 Oct 2022

Researchers propose origin-of-life molecule as therapeutic target for tailored cancer therapies

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cancer.

28 Oct 2022

Allostatic load may explain racial disparities in stroke outcomes

Ahead of World Stroke Day, Oct. 29, investigators from the Department of Neurology at Cedars-Sinai have new information on stroke-related health disparities.

28 Oct 2022

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers.

28 Oct 2022

Study provides new insights into genetic form of frontotemporal dementia

Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide.

28 Oct 2022

Rehabilitation plus stem cell grafting after spinal cord injury can augment functional outcomes

In recent years, researchers have made measurable progress, using animal models, to promote tissue regeneration in spinal cord injuries (SCI) through implanted neural stem cells or grafts. Other efforts have shown that intensive physical rehabilitation can improve function after SCI by promoting greater or new roles for undamaged or spared cells and neural circuits.

28 Oct 2022

Huntington's disease impairs autophagy in older patients

Huntington's disease, a fatal, inherited neurodegenerative condition, is caused by a genetic error present at birth, though its symptoms often don't begin until middle adulthood.

28 Oct 2022

Wireless, battery-free pacemaker could make life easier for heart disease patients

Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 hospitalizations and nearly 160,000 deaths in the United States each year. Globally, it is estimated that approximately 60 million people are affected by the condition.

28 Oct 2022

People with disabilities strongly affected by online microaggressions

In person, people with disabilities often experience microaggressions – comments or subtle insults based on stereotypes. New types of microaggressions play out online as well, according to new Cornell-led research.

28 Oct 2022

CU Anschutz study details the mechanisms behind the link between shingles and strokes

Scientists investigating why people who have had shingles are at a higher risk of stroke, now believe the answer lies within lipid vesicles called exosomes that shuttle proteins and genetic information between cells, according to new research from the University of Colorado Anschutz Medical Campus.

28 Oct 2022

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Overall cancer death rates continued to decline among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer. From 2014 to 2018, overall cancer incidence, or new cases of cancer, remained stable for men and children but increased for women and adolescents and young adults.

28 Oct 2022

AI models improve the accuracy of diagnosing coronary artery disease

Several recent discoveries show that the accuracy of diagnosing coronary artery disease and predicting patient risk is improved with the help of artificial intelligence (AI) models developed by scientists in the Division of Artificial Intelligence in Medicine at Cedars-Sinai.

28 Oct 2022

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade.

28 Oct 2022

New breakthrough in understanding how deletion of certain genes can lead to cancer growth

Genetic mutations kick start cancers. Some mutations shuffle the genetic code, others come from the deletion of key genes.

28 Oct 2022

Commensal gut microbes from IBD patients produce genotoxic metabolites

Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.

27 Oct 2022

Newly developed chemical compounds show promise as potential anticancer therapy

A University of Kentucky Markey Cancer Center researcher's team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors.

27 Oct 2022

New initiative to improve post-acute stroke care across Montana, Nebraska and North Dakota

The American Heart Association, the world's leading voluntary organization focused on heart and brain health for all, is launching a two-year initiative to expand and enhance post-acute stroke care across Montana, Nebraska and North Dakota, giving all patients the best chance at independent life after stroke.

27 Oct 2022

Medical Condition News

Startup receives federal grant for developing technology to detect and treat stress, anxiety

CHG may be the most effective irrigation solution for use during surgical treatment of bone tumors

UK Markey Cancer Center earns the rigorous NAPRC accreditation

Cleveland Clinic awarded $12 million NIH grant to define how cytokines regulate inflammation

Researchers propose origin-of-life molecule as therapeutic target for tailored cancer therapies

Allostatic load may explain racial disparities in stroke outcomes

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Study provides new insights into genetic form of frontotemporal dementia

Rehabilitation plus stem cell grafting after spinal cord injury can augment functional outcomes

Huntington's disease impairs autophagy in older patients

Wireless, battery-free pacemaker could make life easier for heart disease patients

People with disabilities strongly affected by online microaggressions

CU Anschutz study details the mechanisms behind the link between shingles and strokes

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

AI models improve the accuracy of diagnosing coronary artery disease

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New breakthrough in understanding how deletion of certain genes can lead to cancer growth

Commensal gut microbes from IBD patients produce genotoxic metabolites

Newly developed chemical compounds show promise as potential anticancer therapy

New initiative to improve post-acute stroke care across Montana, Nebraska and North Dakota

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News